{
  "ptid_time": "094_S_1398_2008-05-29",
  "img_path": "/data/qiuhui/data/adni/images/094_S_1398/2008-05-29/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,306 mm³, 68.5% above the reference mean. With a Z-score of 1.57 (94.2th percentile), this represents moderate enlargement; whole brain volume measures 651,686 mm³, 33.1% below the reference mean. With a Z-score of -4.17 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 78.6 years. Gender is Female. Education: 16 years. MMSE: 22.0. Logical Memory: 0.0. Laboratory findings: Total Bilirubin: 0.80 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Pittsburgh compound B: 1.27 SUVR (normal ); Amyloid beta: 698.50 pg/mL (normal ); Total tau: 246.10 pg/mL (normal ); Phosphorylated tau: 17.95 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The data shows profound whole brain atrophy and moderate ventricular enlargement, consistent with structural changes seen in dementia. The MMSE score of 22 suggests cognitive impairment, but normal Aβ, T-tau, and P-tau levels argue against Alzheimer's pathology, pointing more toward non-AD dementia (e.g., vascular or frontotemporal).  \nDiagnosis: Dementia  \nConfidence: Medium (due to conflicting biomarkers and lack of detailed clinical history)",
  "timestamp": "2025-07-26T10:23:32.654269"
}